| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| GlcNAcβ(1-3)[Neu5Acα(2-6)]GalNAc-α-pNP |
|
1858223-99-0 |
詳細(xì)
|
| Gemcitabine-13C,1N2 Hydrochloride |
|
1262897-74-4 |
詳細(xì)
|
| β-Glc-PEG3-Azide |
|
156058-83-2 |
詳細(xì)
|
| Gastrin II Sulfated |
|
19361-51-4 |
詳細(xì)
|
| Glutaryl-L-carnitine lithium salt |
|
102636-82-8 |
詳細(xì)
|
| GSK199 |
|
1549811-53-1 |
詳細(xì)
|
| GW8510 |
|
222036-17-1 |
詳細(xì)
|
| Gadolinium |
|
7440-54-2 |
詳細(xì)
|
| 4-Glycidyloxy-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical |
|
122413-85-8 |
詳細(xì)
|
| Guanosine-3′,5′-cyclic Monophosphate, 8-(2-Aminophenylthio)-Sodium Salt |
|
144509-87-5 |
詳細(xì)
|
| Geranyl monophosphate lithium salt |
|
16750-99-5 |
詳細(xì)
|
| GSK-3 Inhibitor II |
|
478482-75-6 |
詳細(xì)
|
| Gadobutrol Monohydrate |
|
198637-52-4 |
詳細(xì)
|
| GSK-F1 |
|
1402345-92-9 |
詳細(xì)
|
| Glycerol trihexanoate |
|
621-70-5 |
詳細(xì)
|
| Guanidine hydrochloride |
|
50-01-1 |
詳細(xì)
|
| Gibberellins A4/A7 |
|
8030-53-3 |
詳細(xì)
|
| Gentiobiosyloleandrin |
|
53270-25-0 |
詳細(xì)
|
| Gitoxin |
|
4562-36-1 |
詳細(xì)
|
| GSK-3 Inhibitor X |
|
740841-15-0 |
詳細(xì)
|
| Glyceryl trioctanoate |
|
538-23-8 |
詳細(xì)
|
| GNE-490 |
|
1033739-92-2 |
詳細(xì)
|
| Ganoderic Acid B |
|
81907-61-1 |
詳細(xì)
|
| Guanidinium bromide |
|
19244-98-5 |
詳細(xì)
|
| GR 135531 |
|
190277-13-5 |
詳細(xì)
|
| hGCGR Antagonist |
|
438618-32-7 |
詳細(xì)
|
| Grindelic acid |
|
1438-57-9 |
詳細(xì)
|
| Globo-N-tetraose |
|
75660-79-6 |
詳細(xì)
|
| GlcNAcβ(1-4)[Fucα(1-6)]GlcNAc |
|
108964-40-5 |
詳細(xì)
|
| GSK-3β Inhibitor VI |
|
62673-69-2 |
詳細(xì)
|
| GSK 114 |
|
1301761-96-5 |
詳細(xì)
|
| Geranylgeraniol |
|
24034-73-9 |
詳細(xì)
|
| Guanosine 5′-Pyrophosphate Ester 6-Deoxytalose Disodium Salt |
|
18657-20-0 |
詳細(xì)
|
| Ganglioside GD2, Disialo, Human Brain |
|
65988-71-8 |
詳細(xì)
|
| G2-peptide |
|
361443-81-4 |
詳細(xì)
|
| GW2974 |
|
202272-68-2 |
詳細(xì)
|
| GABAA receptor agent 1 |
|
1571-87-5 |
詳細(xì)
|
| Geodin hydrate |
|
3209-10-7 |
詳細(xì)
|
| GSK-3 Inhibitor XIII |
|
404828-08-6 |
詳細(xì)
|
| Guanosine 5′-triphosphate tris salt |
|
103192-46-7 |
詳細(xì)
|
| GSK269962A HCl |
|
2095432-71-4 |
詳細(xì)
|
| Gluconic acid sodium salt |
|
527-07-1 |
詳細(xì)
|
| 3-G1F 2AB (500pmol/vial) |
|
1107646-30-9 |
詳細(xì)
|
| GSK J4 |
|
1373423-53-0 |
詳細(xì)
|
| 6-(gamma,gamma-Dimethylallylamino)purine riboside hemihydrate |
|
33156-15-9 |
詳細(xì)
|
| GEN-6776 |
|
2009273-71-4 |
詳細(xì)
|
| GsMTx4 TFA |
|
1209500-46-8 |
詳細(xì)
|
| Glycitin 6′′-O-Acetate |
|
134859-96-4 |
詳細(xì)
|
| Guanidinium iodide |
|
19227-70-4 |
詳細(xì)
|
| Guanosine-1N 5′-monophosphate disodium salt |
|
1257650-86-4 |
詳細(xì)
|
| GSK2838232 |
|
1443461-21-9 |
詳細(xì)
|
| ()-Globulol |
|
489-41-8 |
詳細(xì)
|
| 6-G1F 2AB (500pmol/vial) |
|
1107646-29-6 |
詳細(xì)
|
| β-GlcNAc-PEG3-Azide |
|
86520-54-9 |
詳細(xì)
|
| GlcNAc1-b-6GalNAc-α-PNP |
|
235752-73-5 |
詳細(xì)
|
| Glycyrrhizic acid ammonium salt from glycyrrhiza root (licorice) |
|
53956-04-0 |
詳細(xì)
|
| Gatifloxacin sesquihydrate |
|
180200-66-2 |
詳細(xì)
|
| GM 1489 |
|
170905-75-6 |
詳細(xì)
|
| GlcNPhth[346Ac]β(1-3)Gal[246Bn]-β-MP |
|
1820575-44-7 |
詳細(xì)
|
| Gluconic acid potassium salt |
|
299-27-4 |
詳細(xì)
|
| Glycerol 1-Oleyl Ether |
|
593-31-7 |
詳細(xì)
|
| Glycogen Phosphorylase Inhibitor inhibitor |
|
648926-15-2 |
詳細(xì)
|
| GSK467 |
|
1628332-52-4 |
詳細(xì)
|
| Goethite |
|
20344-49-4 |
詳細(xì)
|
| G-Protein antagonist peptide TFA |
|
143675-79-0 |
詳細(xì)
|
| Glutathione Monoethyl Ester |
|
118421-50-4 |
詳細(xì)
|
| Gold(I) sodium thiosulfate hydrate |
|
10210-36-3 |
詳細(xì)
|
| Ganglioside GD1a disodium salt |
|
12707-58-3 |
詳細(xì)
|
| Glycolic acid ethoxylate oleyl ether |
|
57635-48-0 |
詳細(xì)
|
| Gold sodium thiomalate |
|
12244-57-4 |
詳細(xì)
|
| GRP-60367 |
|
1309241-34-6 |
詳細(xì)
|
| GBR 13069 dihydrochloride |
|
77862-93-2 |
詳細(xì)
|
| 6-Geranyl-7-hydroxycoumarin |
|
148-83-4 |
詳細(xì)
|
| Gadolinium silicide |
|
12134-75-7 |
詳細(xì)
|
| Guaiene |
|
88-84-6 |
詳細(xì)
|
| Glycyl-L-tyrosine Hydrate |
|
207300-83-2 |
詳細(xì)
|
| α-GalNAc-PEG3-Azide |
|
882873-70-3 |
詳細(xì)
|
| Grubbs Catalyst M201 |
|
1307233-23-3 |
詳細(xì)
|
| GLP-1 (9-36) amide TFA |
|
161748-29-4 |
詳細(xì)
|
| GSK2200150A |
|
1443138-53-1 |
詳細(xì)
|
| Galicaftor (ABBV-2222) |
|
1918143-53-9 |
詳細(xì)
|
| Gallic acid monohydrate |
|
5995-86-8 |
詳細(xì)
|
| Ganoderic Acid H |
|
98665-19-1 |
詳細(xì)
|
| GlcNAcβ(1-2)Man-α-ethylazide |
|
1858224-15-3 |
詳細(xì)
|
| Glycine tert-butyl ester dibenzenesulfonimide salt |
|
77284-30-1 |
詳細(xì)
|
| Genistein 4′-β-D-Glucuronide |
|
245084-07-5 |
詳細(xì)
|
| GSK-3β Inhibitor XI |
|
626604-39-5 |
詳細(xì)
|
| Glycidyl palmitate-d5 |
|
1794941-80-2 |
詳細(xì)
|
| Guanylin (human) TFA |
|
183200-12-6 |
詳細(xì)
|
| Guanosine 3′,5′-cyclic Monophosphate, b-Phenyl-1,N2-etheno-8-bromo-, Sodium Salt |
|
144510-04-3 |
詳細(xì)
|
| Gramicidin TFA |
|
1405-97-6 |
詳細(xì)
|
| Garcinoic acid |
|
91893-83-3 |
詳細(xì)
|
| Glyceryl trielaidate |
|
537-39-3 |
詳細(xì)
|
| Gibberellin A8 |
|
7044-72-6 |
詳細(xì)
|
| G1T38 |
|
1628256-23-4 |
詳細(xì)
|
| H-Gly-Pro-AMC · HBr |
|
115035-46-6 |
詳細(xì)
|
| Glisoxepid |
|
25046-79-1 |
詳細(xì)
|
| Glycine 7-amido-4-methylcoumarin hydrobromide |
|
113728-13-5 |
詳細(xì)
|
| Ganglioside GQ1b tetrasodium salt |
|
68652-37-9 |
詳細(xì)
|
| Globo-H Ceramide |
|
177475-60-4 |
詳細(xì)
|